Impact of Surgical Margin Distance on Oncologic Outcomes in Vulvar Squamous Cell Carcinoma

<b>Introduction:</b> Vulvar carcinoma is a rare malignancy with approximately 3090 cases annually in Germany. Squamous cell carcinoma of the vulva (SCC) can be HPV-associated or non-HPV-associated. Surgical excision is the primary treatment, but the optimal tumor-free resection margin remains debated. This study evaluates the impact of resection margin distance on disease prognosis in SCC patients. <b>Methods:</b> A retrospective analysis was conducted on patients diagnosed with SCC of the vulva at the University Hospital of Cologne between 2007 and 2022. Patients with TNM stage pT1a or higher who underwent primary surgical treatment with a tumor-free resection margin status were included. The cohort of 73 patients was divided into three groups based on resection margin distance: >0.01-<0.3 cm (Group 1), ≥0.3-<0.8 cm (Group 2), and ≥0.8 cm (Group 3). Statistical analyses including logrank tests were performed to assess correlations between resection margin distance and recurrence, disease-free survival (DFS), and overall survival (OS). <b>Results:</b> A total of 37.0% of patients were categorized into Group 1, 48.0% into Group 2, and 15.1% into Group 3. Disease recurrence occurred in 26% of patients, with rates of 31.6% in Group 1 (minimum resection margin distance), 42.1% in Group 2, and 26.3% in Group 3. The prevalence of recurrence was not dependent on resection margin distance (<i>p</i> = 0.28). Similarly, the prevalence of deaths was not dependent on resection margin distance (<i>p</i> = 0.43). Disease-free survival (DFS) and overall survival (OS) did not show significant differences between the groups (<i>p</i> = 0.25 and <i>p</i> = 0.87, respectively). <b>Conclusions:</b> This study found no significant impact of pathological tumor-free resection margin distance on DFS or OS in patients with SCC of the vulva. Given the heterogeneity in international guidelines and existing literature, further studies with larger patient cohorts are needed to establish definitive surgical recommendations.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-06-08
DOI
https://doi.org/10.3390/jcm14124057
Citations
1
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Surgical Margin Distance on Oncologic Outcomes in Vulvar Squamous Cell Carcinoma

Peter Mallmann, Caroline Lenz, Fabinshy Thangarajah, B Morgenstern et al.
1 citations
Journal of Clinical Medicine
Cervical Cancer and HPV Research
1.35
article

Impact of Surgical Margin Distance on Oncologic Outcomes in Vulvar Squamous Cell Carcinoma

Peter Mallmann, Caroline Lenz, Fabinshy Thangarajah, B Morgenstern, Su Ir Lyu
article en
1 citations

Abstract

<b>Introduction:</b> Vulvar carcinoma is a rare malignancy with approximately 3090 cases annually in Germany. Squamous cell carcinoma of the vulva (SCC) can be HPV-associated or non-HPV-associated. Surgical excision is the primary treatment, but the optimal tumor-free resection margin remains debated. This study evaluates the impact of resection margin distance on disease prognosis in SCC patients. <b>Methods:</b> A retrospective analysis was conducted on patients diagnosed with SCC of the vulva at the University Hospital of Cologne between 2007 and 2022. Patients with TNM stage pT1a or higher who underwent primary surgical treatment with a tumor-free resection margin status were included. The cohort of 73 patients was divided into three groups based on resection margin distance: >0.01-<0.3 cm (Group 1), ≥0.3-<0.8 cm (Group 2), and ≥0.8 cm (Group 3). Statistical analyses including logrank tests were performed to assess correlations between resection margin distance and recurrence, disease-free survival (DFS), and overall survival (OS). <b>Results:</b> A total of 37.0% of patients were categorized into Group 1, 48.0% into Group 2, and 15.1% into Group 3. Disease recurrence occurred in 26% of patients, with rates of 31.6% in Group 1 (minimum resection margin distance), 42.1% in Group 2, and 26.3% in Group 3. The prevalence of recurrence was not dependent on resection margin distance (<i>p</i> = 0.28). Similarly, the prevalence of deaths was not dependent on resection margin distance (<i>p</i> = 0.43). Disease-free survival (DFS) and overall survival (OS) did not show significant differences between the groups (<i>p</i> = 0.25 and <i>p</i> = 0.87, respectively). <b>Conclusions:</b> This study found no significant impact of pathological tumor-free resection margin distance on DFS or OS in patients with SCC of the vulva. Given the heterogeneity in international guidelines and existing literature, further studies with larger patient cohorts are needed to establish definitive surgical recommendations.

Journal of Clinical MedicineVol. 14(12)
Düsseldorf University Hospital (DE), Essen University Hospital (DE), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE)
Good health and well-being
Openalex Percentile: Top 19%
Cervical Cancer and HPV Research
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.